Across TCGA pan-cancer cohorts, GANC Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GANC data layer compared with 27 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GANC Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated GANC expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, BLCA, and CHOL are the cancer types where GANC Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.940	0.597	.004	30	view →
BLCA	OS	Median	IV	0.035	0.606	<.001	12	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: GANC tumor-vs-normal RNA expression · all GANC data types